These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7839674)

  • 21. Activated macrophages and the blood-brain barrier: inflammation after CNS injury leads to increases in putative inhibitory molecules.
    Fitch MT; Silver J
    Exp Neurol; 1997 Dec; 148(2):587-603. PubMed ID: 9417835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of blood and serum markers in spinal cord injured patients with pressure sores.
    Gurcay E; Bal A; Gurcay AG; Cakci A
    Saudi Med J; 2009 Mar; 30(3):413-7. PubMed ID: 19271073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Middle molecules in hepatic coma and uremia.
    Chang TM; Lister C
    Artif Organs; 1981; 4 Suppl():169-72. PubMed ID: 7295086
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of uremic middle molecules on in vitro stimulated lymphocytes and interleukin-2 production.
    Severini G; Diana L; Di Giovannandrea R; Sagliaschi G
    ASAIO J; 1996; 42(1):64-7. PubMed ID: 8808461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of middle molecules in the cerebrospinal fluid of uremic patients].
    Sperschneider H; Spustova V; Stein G; Dzurik R
    Z Gesamte Inn Med; 1981 Dec; 36(23):926-30. PubMed ID: 7342520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum amino acids as indicators of cerebrospinal neuronal activity in patients with micturition disorders.
    Nishijima S; Sugaya K; Fukuda T; Miyazato M; Ashimine S; Ogawa Y
    Int J Urol; 2006 Dec; 13(12):1479-83. PubMed ID: 17118021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Middle molecules" in acute experimental uremia.
    Lutz W; Madry K; Grande G
    Acta Med Pol; 1978; 19(4):417-24. PubMed ID: 752244
    [No Abstract]   [Full Text] [Related]  

  • 28. Tauroursodeoxycholic acid and secondary damage after spinal cord injury in rats.
    Colak A; Kelten B; Sağmanligil A; Akdemir O; Karaoğlan A; Sahan E; Celik O; Barut S
    J Clin Neurosci; 2008 Jun; 15(6):665-71. PubMed ID: 18343118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate.
    Ringoir SM; van Landschoot N; de Smet R
    Clin Nephrol; 1980 Mar; 13(3):109-12. PubMed ID: 7379359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relation between serum MDA and cystatin C levels in chronic spinal cord injury patients.
    Koçak H; Oner-Iyidoğan Y; Gürdöl F; Koçak T; Esin D
    Clin Biochem; 2005 Nov; 38(11):1034-7. PubMed ID: 16154555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinase-9 activity in the cerebrospinal fluid and serum of dogs with acute spinal cord trauma from intervertebral disk disease.
    Levine JM; Ruaux CG; Bergman RL; Coates JR; Steiner JM; Williams DA
    Am J Vet Res; 2006 Feb; 67(2):283-7. PubMed ID: 16454634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic value of determining middle molecules in the blood plasma in nephrological diseases].
    Gabriélian NI; Dmitriev AA; Kulakov GP; Melikian AM; Shcherbaneva OI
    Klin Med (Mosk); 1981 Oct; 59(10):38-42. PubMed ID: 7311409
    [No Abstract]   [Full Text] [Related]  

  • 33. A defense of the middle molecule hypothesis.
    Funck-Brentano JL; Cueille GF; Man NK
    Kidney Int Suppl; 1978 Jun; (8):S31-5. PubMed ID: 278894
    [No Abstract]   [Full Text] [Related]  

  • 34. Topical application of dynorphin A (1-17) antiserum attenuates trauma induced alterations in spinal cord evoked potentials, microvascular permeability disturbances, edema formation and cell injury: an experimental study in the rat using electrophysiological and morphological approaches.
    Winkler T; Sharma HS; Gordh T; Badgaiyan RD; Stålberg E; Westman J
    Amino Acids; 2002; 23(1-3):273-81. PubMed ID: 12373547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromatographic analysis of middle molecules in plasma ultrafiltrates of uraemic patients.
    Popławski A; Myśliwiec M
    Nephrol Dial Transplant; 1993; 8(2):188. PubMed ID: 8384345
    [No Abstract]   [Full Text] [Related]  

  • 36. Recombinant human erythropoietin decreases myeloperoxidase and caspase-3 activity and improves early functional results after spinal cord injury in rats.
    Okutan O; Solaroglu I; Beskonakli E; Taskin Y
    J Clin Neurosci; 2007 Apr; 14(4):364-8. PubMed ID: 17236773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Nursing patients with craniocerebral trauma and with spinal cord injuries].
    Bashina VI
    Med Sestra; 1979 Jan; 38(1):44-6. PubMed ID: 253911
    [No Abstract]   [Full Text] [Related]  

  • 38. ["Middle molecules" as nonspecific regulators of phagocyte activity].
    Volchegorskiĭ IA; Vlasov AV; Livshits GE; Akhkiamov EM; Skobeleva NA; Lifshits RI; Ebert LIa
    Biull Eksp Biol Med; 1995 Feb; 119(2):159-62. PubMed ID: 7670039
    [No Abstract]   [Full Text] [Related]  

  • 39. [Toxicity of the cerebrospinal fluid in comas of various etiologies].
    Belokurov MIu; Lushchilova VD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(12):1781-2. PubMed ID: 3447391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Biochemical definition of uremia].
    Ringoir S
    Verh K Acad Geneeskd Belg; 1981; 43(2):105-19. PubMed ID: 7314875
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.